Sign in
4

Changes in Ownership

Vir Biotechnology, Inc. Filed Acc 0001628280-26-074055

SVP, Chief Accounting Officer acquired 50,000 shares (grant or award)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Sabatini Brent · SVP, Chief Accounting Officer

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2026-11-15 Grant or award : show line 1 in the form 10b5-1 +50,000 111,902 D
Loading xslF345X06/wk-form4_1794849335.xml…